Biotech Values

[semi_infinite]

Not enough details in the powerpoint slides to tell what happened to the heart patients. so my concerns remain on the late 2016 poster (461), ie how is reduced contractility and lower ejection fraction good for HCM patients? Sure gradient goes down because of less blood flow but that cannot be the lone metric or path for reversing fibrosis. Lets assume the positive and it works. Then the question becomes how long is a good for and whether it just delays surgery or alcohol ablation. I don't know if Entresto is being tried on HCM patients and if so, how that is working. Enalapril and other beta blockers have bad side effects but no good choices out there so I hope MYOK succeeds. 491 sounds interesting but again not enough details.